Insufficient scRNA-seq data for expression of ELANE at single-cell level.
Insufficient scRNA-seq data for expression of ELANE at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 97% | 157.41 | 632 / 653 | 23% | 0.93 | 142 / 605 |
prostate | 88% | 148.73 | 215 / 245 | 32% | 0.61 | 159 / 502 |
lung | 97% | 712.90 | 561 / 578 | 15% | 4.45 | 174 / 1155 |
breast | 97% | 165.88 | 444 / 459 | 10% | 0.20 | 116 / 1118 |
bladder | 95% | 101.71 | 20 / 21 | 6% | 0.19 | 32 / 504 |
spleen | 98% | 1591.22 | 237 / 241 | 0% | 0 | 0 / 0 |
adipose | 96% | 153.42 | 1156 / 1204 | 0% | 0 | 0 / 0 |
heart | 87% | 103.72 | 747 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 6787.17 | 755 / 929 | 0% | 0 | 0 / 0 |
intestine | 77% | 85.99 | 742 / 966 | 4% | 0.20 | 20 / 527 |
skin | 75% | 138.00 | 1351 / 1809 | 4% | 0.15 | 19 / 472 |
esophagus | 74% | 95.63 | 1074 / 1445 | 4% | 0.11 | 8 / 183 |
adrenal gland | 59% | 36.56 | 151 / 258 | 18% | 1.16 | 41 / 230 |
stomach | 65% | 51.22 | 233 / 359 | 9% | 0.30 | 25 / 286 |
muscle | 47% | 29.71 | 377 / 803 | 0% | 0 | 0 / 0 |
kidney | 36% | 21.63 | 32 / 89 | 7% | 0.33 | 66 / 901 |
brain | 15% | 8.31 | 390 / 2642 | 22% | 0.55 | 157 / 705 |
liver | 33% | 63.18 | 74 / 226 | 4% | 0.12 | 16 / 406 |
pancreas | 9% | 4.75 | 28 / 328 | 25% | 11.98 | 45 / 178 |
blood vessel | 31% | 26.24 | 410 / 1335 | 0% | 0 | 0 / 0 |
uterus | 28% | 19.66 | 47 / 170 | 3% | 0.11 | 14 / 459 |
ovary | 23% | 19.07 | 42 / 180 | 1% | 0.02 | 5 / 430 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0070947 | Biological process | neutrophil-mediated killing of fungus |
GO_0070945 | Biological process | neutrophil-mediated killing of gram-negative bacterium |
GO_0002523 | Biological process | leukocyte migration involved in inflammatory response |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_0009411 | Biological process | response to UV |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0050922 | Biological process | negative regulation of chemotaxis |
GO_0002812 | Biological process | biosynthetic process of antibacterial peptides active against Gram-negative bacteria |
GO_1903238 | Biological process | positive regulation of leukocyte tethering or rolling |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0006508 | Biological process | proteolysis |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0006909 | Biological process | phagocytosis |
GO_0030163 | Biological process | protein catabolic process |
GO_0042742 | Biological process | defense response to bacterium |
GO_0032682 | Biological process | negative regulation of chemokine production |
GO_0001878 | Biological process | response to yeast |
GO_0050778 | Biological process | positive regulation of immune response |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0002438 | Biological process | acute inflammatory response to antigenic stimulus |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0030141 | Cellular component | secretory granule |
GO_0008201 | Molecular function | heparin binding |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0019955 | Molecular function | cytokine binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0002020 | Molecular function | protease binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | ELANE |
Protein name | Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase) |
Synonyms | ELA2 |
Description | FUNCTION: Serine protease that modifies the functions of natural killer cells, monocytes and granulocytes. Inhibits C5a-dependent neutrophil enzyme release and chemotaxis . Promotes cleavage of GSDMB, thereby inhibiting pyroptosis . Capable of killing E.coli but not S.aureus in vitro; digests outer membrane protein A (ompA) in E.coli and K.pneumoniae . . |
Accessions | ENST00000615489.1 ENST00000632488.1 P08246 ENST00000263621.2 ENST00000590230.5 |